Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, J Frank W Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee de Geus-Oei, Mark C Burgmans
PURPOSE: The aim of this study was to investigate the biodistribution of (super-)selective trans-arterial radioembolization (TARE) with holmium-166 microspheres (166 Ho-MS), when administered as adjuvant therapy after RFA of HCC 2-5 cm. The objective was to establish a treatment volume absorbed dose that results in an absorbed dose of ≥ 120 Gy on the hyperemic zone around the ablation necrosis (i.e., target volume). METHODS: In this multicenter, prospective dose-escalation study in BCLC early stage HCC patients with lesions 2-5 cm, RFA was followed by (super-)selective infusion of 166 Ho-MS on day 5-10 after RFA...
February 8, 2024: European Journal of Nuclear Medicine and Molecular Imaging